ARTICLE | Company News
Bristol-Myers Squibb withdraws NDA
March 17, 2000 8:00 AM UTC
BMY withdrew the NDA for its UFT tegafur uracil capsules for use with leucovorin calcium tablets in the first-line treatment of advanced colorectal cancer. On Sept. 16, 1999, the FDA's Oncologic Drugs...